相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of levodopa therapy-induced complications on quality of life in Parkinson's disease patients in Singapore
Jonathan Wu et al.
SCIENTIFIC REPORTS (2019)
DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease
Carlo Purcaro et al.
NEUROSCIENCE LETTERS (2019)
MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease
Tiago Furtado Sampaio et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
International Parkinson and Movement Disorder Society Evidence-Based Medicine Review: Update on Treatments for the Motor Symptoms of Parkinson's Disease
Susan H. Fox et al.
MOVEMENT DISORDERS (2018)
Association of a neuronal nitric oxide synthase gene polymorphism with levodopa-induced dyskinesia in Parkinson's disease
Bruno Lopes Santos-Lobato et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2018)
Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease
Cynthia D. J. Kusters et al.
PARKINSONISM & RELATED DISORDERS (2018)
Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease
Cristoforo Comi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
A Web Resource for Levodopa-Induced Dyskinesia Genetics in Parkinson's Disease
Hagen Blankenburg et al.
NEUROINFORMATICS (2017)
Risk and course of motor complications in a population-based incident Parkinson's disease cohort
Anders Bjornestad et al.
PARKINSONISM & RELATED DISORDERS (2016)
Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Parkinson's disease patients?
Mariana Rieck et al.
PHARMACOGENOMICS (2015)
Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease
H. Z. Hashim et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)
Sequence Variants in SLC6A3, DRD2, and BDNF Genes and Time to Levodopa-Induced Dyskinesias in Parkinson's Disease
Natalie Kaplan et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Influence of Single Nucleotide Polymorphisms in COMT, MAO-A and BDNF Genes on Dyskinesias and Levodopa Use in Parkinson's Disease
Perdita Cheshire et al.
NEURODEGENERATIVE DISEASES (2014)
Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population
Hongying Hao et al.
PARKINSONISM & RELATED DISORDERS (2014)
Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson's disease patients
A. F. Schumacher-Schuh et al.
PHARMACOGENOMICS JOURNAL (2014)
Do Tardive Dyskinesia and Dopa Induced Dyskinesia Share Common Genetic Risk Factors? An Exploratory Study
Lior Greenbaum et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Catechol-O-methyltransferase Val158Met and the Risk of Dyskinesias in Parkinson's Disease
Lonneke M. L. de lau et al.
MOVEMENT DISORDERS (2012)
Dyskinesias in patients with Parkinson's disease: Effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation
Gilad Yahalom et al.
PARKINSONISM & RELATED DISORDERS (2012)
DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson's disease patients
Mariana Rieck et al.
PHARMACOGENOMICS (2012)
NMDA receptor genotypes associated with the vulnerability to develop dyskinesia
S. A. Ivanova et al.
TRANSLATIONAL PSYCHIATRY (2012)
The role of apolipoprotein E polymorphisms in levodopa-induced dyskinesia
I. Molchadski et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study
Manju A. Kurian et al.
LANCET NEUROLOGY (2011)
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
Robert A. Hauser et al.
LANCET NEUROLOGY (2011)
Differential Genetic Susceptibility in Diphasic and Peak-Dose Dyskinesias in Parkinson's Disease
Jee-Young Lee et al.
MOVEMENT DISORDERS (2011)
A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease
Kenya Nishioka et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease
T. Foltynie et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Clinical Pattern and Risk Factors for Dyskinesias Following Fetal Nigral Transplantation in Parkinson's Disease: A Double Blind Video-Based Analysis
C. Warren Olanow et al.
MOVEMENT DISORDERS (2009)
Motor Complications in Patients Form the German Competence Network on Parkinson's Disease and the DRD3 Ser9Gly Polymorphism
Sebastian Paus et al.
MOVEMENT DISORDERS (2009)
The ANKK1 Kinase Gene and Psychiatric Disorders
Guillermo Ponce et al.
NEUROTOXICITY RESEARCH (2009)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
IS THE COMMON LRRK2 G2019S MUTATION RELATED TO DYSKINESIAS IN NORTH AFRICAN PARKINSON DISEASE?
S. Lesage et al.
NEUROLOGY (2008)
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications
Monika Bialecka et al.
PHARMACOGENETICS AND GENOMICS (2008)
The HGNC Database in 2008: a resource for the human genome
Elspeth A. Bruford et al.
NUCLEIC ACIDS RESEARCH (2008)
Trends in meta-analysis of genetic association studies
Elias Zintzaras et al.
JOURNAL OF HUMAN GENETICS (2008)
Levodopa-induced dyskinesias
Giovanni Fabbrini et al.
MOVEMENT DISORDERS (2007)
Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease
Judith A. Strong et al.
MOVEMENT DISORDERS (2006)
Nondopaminergic mechanisms in levodopa-induced dyskinesia
JA Brotchie
MOVEMENT DISORDERS (2005)
Characterization of the in vitro transcriptional activity of polymorphic alleles of the human monoamine oxidase-B gene
P Costa-Mallen et al.
NEUROSCIENCE LETTERS (2005)
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic -: Pharmacodynarnic pattern in patients with Parkinson's disease
M Contin et al.
MOVEMENT DISORDERS (2005)
Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease -: An exploratory study
M Zappia et al.
ARCHIVES OF NEUROLOGY (2005)
Continuous dopaminergic stimulation in early and advanced Parkinson's disease
F Stocchi et al.
NEUROLOGY (2004)
Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1
MJ Neville et al.
HUMAN MUTATION (2004)
Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's disease
Y Gilgun-Sherki et al.
PHARMACOGENOMICS JOURNAL (2004)
The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease
M Bialecka et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias
F Calon et al.
BRAIN (2004)
A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease
F Bibbiani et al.
EXPERIMENTAL NEUROLOGY (2003)
Sample size calculations for population- and family-based case-control association studies on marker genotypes
RM Pfeiffer et al.
GENETIC EPIDEMIOLOGY (2003)
L-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
R Kaiser et al.
NEUROLOGY (2003)
Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of L-DOPA-induced dyskinesia
M Lundblad et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Data adaptive interim modification of sample sizes for candidate-gene association studies
A Scherag et al.
HUMAN HEREDITY (2003)
Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease
M Watanabe et al.
NEUROPSYCHOBIOLOGY (2003)
Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson's disease
JJ Lin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
dbSNP: the NCBI database of genetic variation
ST Sherry et al.
NUCLEIC ACIDS RESEARCH (2001)
Platelet monoamine oxidase activity is related to MAOB intron 13 genotype
H Garpenstrand et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
分享论文
